Further clinical correlation analysis reveals that high ALG3 expression is significantly associated with tumor size, tumor stage, microvascular invasion (MVI), and clinical staging, all of which are key predictors of HCC progression and prognosis. This evidence concerns the gene ALG3 and hepatocellular carcinoma.